Influenza Immunization for Seniors, Canadian Institute for Health Information

	A	B	C	D	E	F	G	H	I	J
1	https://www.cihi.ca/sites/default/files/cphi-data-tables-influenza_en.xlsx
2
3	Table of Contents
4
5	Influenza Immunization for Seniors (Canada)
6
7	Both Sexes	2003	2005	2007–2008	2009–2010	2011–2012	2013	Change Over Time
8								Direction	Percentage	Difference
9	Age-Standardized Rate (%)
10	All Income Quintiles	67.8	71.9	69.0	64.3	65.4	65.4	↓	-3.6*	-2.4*
11	(95% CI)	(66.9–68.7)	(71.0–72.7)	(68.1–69.9)	(63.3–65.3)	(64.4–66.4)	(64.1–66.7)		(-5.8–-1.3)	(-4.0–-0.8)
12	Q1	63.4	67.3	64.2	60.0	60.4	61.2	—	—	—
13	(95% CI)	(61.9–64.9)	(65.8–68.8)	(62.5–65.8)	(58.2–61.9)	(58.5–62.4)	(58.5–63.9)
14	Q2	65.9	71.2	68.9	64.4	65.5	63.8	—	—	—
15	(95% CI)	(64.2–67.5)	(69.5–72.9)	(67.3–70.6)	(62.5–66.3)	(63.5–67.5)	(61.4–66.1)
16	Q3	74.0	74.9	72.5	68.5	67.3	68.0	↓	-8.1*	-6.0*
17	(95% CI)	(71.9–76.1)	(72.9–76.9)	(70.5–74.6)	(66.5–70.6)	(65.3–69.3)	(65.5–70.4)		(-12.3–-3.9)	(-9.2–-2.8)
18	Q4	73.7	78.1	72.8	67.2	69.5	69.5	—	—	—
19	(95% CI)	(70.6–76.9)	(75.4–80.8)	(70.0–75.5)	(64.5–69.9)	(67.0–72.0)	(66.0–73.0)
20	Q5	75.5	80.0	74.5	69.4	70.2	68.4	—	—	—
21	(95% CI)	(72.2–78.7)	(77.5–82.6)	(71.0–77.9)	(66.0–72.8)	(67.5–73.0)	(64.4–72.4)
22	Disparity Rate Ratio (Q5 ÷ Q1)	1.19*	1.19*	1.16*	1.16*	1.16*	1.12*	—	—	—
23	(95% CI)	(1.13–1.25)	(1.14–1.24)	(1.10–1.22)	(1.09–1.22)	(1.10–1.22)	(1.04–1.20)
24	Disparity Rate Difference (Q5 − Q1)	12.0*	12.7*	10.3*	9.3*	9.8*	7.2*	—	—	—
25	(95% CI)	(8.4–15.6)	(9.7–15.7)	(6.5–14.1)	(5.5–13.2)	(6.4–13.2)	(2.4–12.0)
26	Potential Rate Improvement (%)	9.8*	10.1*	7.4*	6.8*	6.5*	4.5*
27	(95% CI)	(9.3–10.2)	(9.8–10.5)	(7.1–7.8)	(6.5–7.2)	(6.3–6.8)	(4.2–4.8)
28	Population Impact Number	319,900	356,400	275,200	243,100	191,100	89,500
29
30	Men	2003	2005	2007–2008	2009–2010	2011–2012	2013	Change Over Time
31								Direction	Percentage	Difference
32	Age-Standardized Rate (%)
33	All Income Quintiles	68.6	72.5	69.0	65.1	64.7	65.4	↓	-4.7*	-3.2*
34	(95% CI)	(67.3–69.9)	(71.2–73.7)	(67.7–70.4)	(63.6–66.5)	(63.1–66.2)	(63.5–67.2)		(-8.0–-1.5)	(-5.5–-1.0)
35	Q1	63.1	65.2	62.4	60.2	55.6	61.3	—	—	—
36	(95% CI)	(60.4–65.9)	(62.5–67.9)	(59.6–65.2)	(57.0–63.4)	(52.0–59.3)	(57.2–65.5)
37	Q2	66.3	72.1	67.8	64.0	64.6	61.5	—	—	—
38	(95% CI)	(63.7–68.9)	(69.6–74.6)	(65.4–70.3)	(61.4–66.7)	(61.6–67.6)	(57.6–65.4)
39	Q3	75.1	73.9	72.1	68.2	66.9	68.3	↓	-9.0*	-6.8*
40	(95% CI)	(72.2–77.9)	(71.2–76.6)	(69.0–75.1)	(65.1–71.3)	(64.2–69.6)	(64.8–71.8)		(-14.8–-3.2)	(-11.3–-2.2)
41	Q4	72.8	79.2	74.1	68.3	68.7	69.2	—	—	—
42	(95% CI)	(68.7–76.9)	(75.7–82.7)	(70.6–77.6)	(64.6–72.0)	(65.3–72.1)	(64.7–73.7)
43	Q5	73.7	80.6	74.9	70.4	72.3	69.1	—	—	—
44	(95% CI)	(69.7–77.7)	(77.4–83.9)	(70.8–79.0)	(66.5–74.3)	(69.2–75.4)	(64.4–73.8)
45	Disparity Rate Ratio (Q5 ÷ Q1)	1.17*	1.24*	1.20*	1.17*	1.30*	1.13*	—	—	—
46	(95% CI)	(1.09–1.25)	(1.17–1.31)	(1.12–1.29)	(1.08–1.26)	(1.20–1.41)	(1.02–1.24)
47	Disparity Rate Difference (Q5 − Q1)	10.5*	15.4*	12.5*	10.2*	16.7*	7.8*	—	—	—
48	(95% CI)	(5.7–15.4)	(11.2–19.6)	(7.5–17.4)	(5.2–15.3)	(11.9–21.5)	(1.5–14.0)
49	Potential Rate Improvement (%)	6.6*	10.3*	7.8*	7.0*	10.0*	5.4*
50	(95% CI)	(6.2–7.0)	(9.8–10.7)	(7.4–8.3)	(6.6–7.5)	(9.5–10.5)	(5.0–5.8)
51	Population Impact Number	99,400	163,600	119,300	100,700	142,000	78,000
52
53	Women	2003	2005	2007–2008	2009–2010	2011–2012	2013	Change Over Time
54								Direction	Percentage	Difference
55	Age-Standardized Rate (%)
56	All Income Quintiles	67.5	71.8	69.1	63.8	66.1	65.3	—	—	—
57	(95% CI)	(66.3–68.6)	(70.6–72.9)	(67.9–70.3)	(62.4–65.1)	(64.8–67.3)	(63.5–67.1)
58	Q1	63.9	68.8	65.5	60.0	63.2	61.1	—	—	—
59	(95% CI)	(62.1–65.7)	(66.9–70.6)	(63.5–67.5)	(57.9–62.2)	(60.9–65.5)	(57.6–64.7)
60	Q2	66.0	70.7	70.1	64.6	66.2	65.9	—	—	—
61	(95% CI)	(63.8–68.2)	(68.5–72.9)	(67.8–72.3)	(62.0–67.3)	(63.8–68.6)	(63.1–68.6)
62	Q3	73.1	75.4	72.1	68.8	67.6	67.3	—	—	—
63	(95% CI)	(70.2–76.1)	(72.7–78.2)	(69.5–74.7)	(66.0–71.6)	(64.7–70.5)	(64.0–70.6)
64	Q4	73.6	76.3	71.0	66.4	70.0	69.5	—	—	—
65	(95% CI)	(69.4–77.9)	(72.1–80.5)	(66.6–75.4)	(62.4–70.3)	(66.7–73.3)	(64.5–74.4)
66	Q5	76.7	79.4	75.2	69.7	68.0	65.5	—	—	—
67	(95% CI)	(71.6–81.7)	(74.7–84.1)	(70.0–80.4)	(64.1–75.4)	(62.7–73.2)	(58.6–72.5)
68	Disparity Rate Ratio (Q5 ÷ Q1)	1.20*	1.15*	1.15*	1.16*	1.08	1.07	—	—	—
69	(95% CI)	(1.12–1.29)	(1.08–1.23)	(1.06–1.24)	(1.06–1.27)	(0.99–1.17)	(0.95–1.21)
70	Disparity Rate Difference (Q5 − Q1)	12.8*	10.6*	9.7*	9.7*	4.8	4.4	—	—	—
71	(95% CI)	(7.4–18.1)	(5.6–15.6)	(4.1–15.3)	(3.7–15.8)	(-0.9–10.5)	(-3.4–12.2)
72	Potential Rate Improvement (%)	11.9*	9.8*	8.2*	8.1*	2.7*	0.6*
73	(95% CI)	(11.1–12.7)	(9.2–10.4)	(7.6–8.8)	(7.5–8.8)	(2.5–2.9)	(0.6–0.7)
74	Population Impact Number	220,500	192,800	155,900	142,400	49,100	11,500
75
76	Influenza Immunization for Seniors (British Columbia)
77
78	Both Sexes	2003	2005	2007–2008	2009–2010	2011–2012	2013	Change Over Time
79	Both Sexes	2003	2005	2007–2008	2009–2010	2011–2012	2013	Direction	Percentage	Difference
80	Age-Standardized Rate (%)
81	All Income Quintiles	67.7	73.2	66.1	65.1	64.3	64.1	—	—	—
82	(95% CI)	(65.4–70.0)	(71.0–75.4)	(63.9–68.3)	(62.5–67.6)	(61.7–66.8)	(61.0–67.2)
83	Q1	65.0	68.0	64.5	63.4	60.7	52.2	↓	-19.7*	-12.8*
84	(95% CI)	(61.0–69.0)	(64.3–71.8)	(60.6–68.4)	(58.7–68.0)	(55.5–66.0)	(44.4–60.0)		(-32.6–-6.7)	(-21.5–-4.1)
85	Q2	63.9	74.7	66.1	64.9	63.1	61.6	—	—	—
86	(95% CI)	(59.6–68.2)	(71.1–78.4)	(62.0–70.2)	(59.3–70.6)	(57.8–68.5)	(55.7–67.6)
87	Q3	74.2	73.8	69.9	66.3	65.7	67.3	—	—	—
88	(95% CI)	(69.5–78.8)	(68.3–79.4)	(63.6–76.2)	(61.2–71.4)	(60.7–70.6)	(61.4–73.1)
89	Q4	73.3	77.7	68.0	66.8	71.4	73.1	—	—	—
90	(95% CI)	(67.3–79.3)	(70.9–84.4)	(62.0–74.0)	(60.1–73.6)	(66.1–76.8)	(66.8–79.4)
91	Q5	70.0	81.3	66.4	67.8	66.8	66.3	—	—	—
92	(95% CI)	(62.0–78.0)	(74.6–88.1)	(56.4–76.4)	(61.2–74.5)	(59.4–74.2)	(58.1–74.5)
93	Disparity Rate Ratio (Q5 ÷ Q1)	1.08	1.20*	1.03	1.07	1.10	1.27*	—	—	—
94	(95% CI)	(0.95–1.23)	(1.08–1.32)	(0.88–1.21)	(0.95–1.21)	(0.96–1.27)	(1.05–1.54)
95	Disparity Rate Difference (Q5 − Q1)	5.0	13.3*	1.9	4.5	6.1	14.1*	—	—	—
96	(95% CI)	(-3.9–14.0)	(5.6–21.0)	(-8.8–12.6)	(-3.7–12.6)	(-3.0–15.1)	(2.8–25.4)
97	Potential Rate Improvement (%)	3.0*	9.9*	0.0	3.6*	2.9*	4.0*
98	(95% CI)	(2.7–3.4)	(9.1–10.8)		(3.2–4.0)	(2.6–3.3)	(3.5–4.6)
99	Population Impact Number	18,600	43,800	0	16,400	16,500	21,000
100